文献速递白血病淋巴瘤浆细胞疾病

外周血CD3+ T细胞基因表达生物标志物与血液系统恶性肿瘤患者临床衰弱相关

Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies.
PubMed 文献 · Br J Haematol · 2022-06-29

研究纳入两家机构69例年龄36至92岁(中位76岁)的白血病、淋巴瘤或多发性骨髓瘤患者,检测纯化外周血T细胞中74种免疫、衰老及衰老相关信使RNA的表达。发现AHR、CD27、CD28和IL2RA(CD25)四个基因的T细胞表达与衰弱相关且独立于年龄,基于表达的回归模型判定患者为健壮的敏感度为76%、特异度为90%。

要点

  • 四个基因AHR、CD27、CD28、IL2RA在T细胞的表达与衰弱相关,独立于年龄。
  • 基于表达的回归模型判定健壮状态的敏感度为76%、特异度为90%。
  • 外周血可测量指标与临床衰弱相关,作者提示可作为未来前瞻性评估的生物标志物。

核心结论

  • 外周血T细胞中AHR、CD27、CD28和IL2RA的表达与血液系统恶性肿瘤患者的临床衰弱相关且独立于年龄。
  • 基于表达的回归模型判定患者为健壮的敏感度为76%、特异度为90%。
  • 作者提示这些数据识别了临床衰弱可测量的外周血相关指标,并提示可用于未来前瞻性评估的生物标志物。

研究设计与样本

  • 研究纳入两家机构69例年龄36至92岁(中位76岁)的白血病、淋巴瘤或多发性骨髓瘤患者。
  • 检测纯化外周血T细胞中74种免疫细胞、衰老及衰老相关信使RNA的表达特征,分析其与临床衰弱的关系。

主要发现

  • T细胞中AHR、CD27、CD28和IL2RA(CD25)四个基因的表达与衰弱相关,独立于年龄。
  • 基于表达的回归模型判定患者为健壮的敏感度为76%、特异度为90%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Older patients with cancer often receive treatment regimens based on their age without considering other objective factors that may influence outcomes. Assessment of frailty can identify older patients who are robust and therefore more likely to benefit from intensive treatment, or conversely, frail and might instead be offered alternative approaches. However, such assessment requires specialised training and dedicated clinical resources. Alternative quantitative biomarkers associated with frailty are lacking. Here, we asked if expression signatures of 74 immune cell, ageing, and senescence-related messenger RNAs in purified peripheral blood T cells could identify associations with clinical frailty in patients with haematological malignancies. We studied 69 patients between the ages of 36 and 92 years (median 76 years) with leukaemia, lymphoma, or multiple myeloma, across two institutions. Expression of four genes (aryl hydrocarbon receptor [AHR], CD27, CD28, and interleukin-2 receptor subunit alpha [IL2RA; CD25]) in T cells was associated with frailty, independent of age. An expression-based regression model had 76% sensitivity and 90% specificity to assign a patient as robust. These data identify measurable peripheral blood correlates of clinical frailty and suggest biomarkers for future prospective assessment.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Fell G, Rosko AE, Abel GA, et al. Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies. Br J Haematol. 2022. PMID: 35766906. doi:10.1111/bjh.18336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。